Explained | Could a photography dispute in the U.S. affect ChatGPT and its cousins?

Copyright law protects the work of diverse artists, including photographers, as well as provides a set of exclusive rights for artists over their creative output. This includes controlling the manner in which others reproduce or modify their work. However, these exclusive rights are balanced with the rights of the users of such work, including other artists who might want to build on or comment on them, with the help of diverse exceptions under copyright law.

What is exempt from infringement liability?

Different jurisdictions follow different approaches to exceptions. Some, particularly countries in continental Europe, adopt the ‘enumerated exceptions approach’: the use in question needs to be specifically covered under the statute to be considered as an exception to infringement. Some others, including the U.S., follow an open-ended approach that doesn’t specify exemptions beforehand; instead, they have guidelines about the types of uses that can be exempted.

The U.S. courts primarily consider four factors when determining whether a particular use can be considered to be an instance of fair use: (1) purpose and character of the use; (2) nature of the copyrighted work; (3) amount and substantiality of the portion taken by the defendant, and (4) effect of the use on the potential market of the plaintiff’s work.

Of these, U.S. courts have been giving the highest importance to the first factor. In particular, whether the use of something can be considered “transformative” has often played the most critical role in determining the final outcome in a fair-use case.

This open-ended approach to exceptions provides U.S. copyright law considerable flexibility and strength to deal with challenges posed by emerging technologies on the copyright system. However, it has a major limitation: there is no way to know whether an activity will be exempted from liabilities until after litigation. That is, it is very hard to predict ex ante whether an activity will be exempted from copyright infringement liabilities.

The recent decision of the U.S. Supreme Court in Andy Warhol Foundation for the Visual Arts Inc. v. Goldsmith et al. has just added more unpredictability to this process – with implications for how we regulate a powerful form of artificial intelligence.

What is the Andy Warhol Foundation case?

Andy Warhol with his pet dachshund, 1973.
| Photo Credit:
Jack Mitchell, CC BY-SA 4.0

Known for her concert and portrait shots, Lynn Goldsmith photographed the famous musician Prince in 1981. One of those photos was licensed in 1984 to Vanity Fair magazine for use as an “artist reference”. The licence specifically said the illustration could appear once as a full page element and once as a one-quarter page element, in the magazine’s November 1984. Vanity Fair paid Ms. Goldsmith $400 for the licence.

It then hired the celebrated visual artist Andy Warhol to work on the illustration. Mr. Warhol made a silkscreen portrait of Prince using Goldsmith’s photo. It appeared in the magazine with appropriate credits to Ms. Goldsmith. But while the licence had authorised only one illustration, Mr. Warhol additionally created 13 screen prints and two pencil sketches.

In 2016, Condé Nast, the media conglomerate that publishes Vanity Fair, approached the Andy Warhol Foundation (AWF) to reuse the 1984 illustration as part of a story on Prince. But when they realised that there were more portraits available, they opted to publish one of them instead (an orange silkscreen portrait). And as part of the licence to use it, they paid $10,000 to AWF, and nothing to Ms. Goldsmith.

When AWF realised that Ms. Goldsmith may file a copyright infringement suit, it filed a suit for declaratory judgment of non-infringement. Ms. Goldsmith then counter-sued AWF for copyright infringement.

What did the courts find?

The front façade of the Supreme Court of the United States in Washington, DC, October 19, 2020.

The front façade of the Supreme Court of the United States in Washington, DC, October 19, 2020.
| Photo Credit:
Ian Hutchinson/Unsplash

First, a district court summarily ruled in favour of AWF, opining that Mr. Warhol’s use of Ms. Goldsmith’s photo constituted fair-use. The court banked on the first factor and held that Mr. Warhol’s work was “transformative” as they “have a different character, give Goldsmith’s photograph a new expression, and employ new aesthetics with creative and communicative results distinct from Goldsmith’s”.

It also observed that Mr. Warhol’s work added something new to the world of art “and the public would be deprived of this contribution if the works could not be distributed”.

However, the Court of Appeals for the Second Circuit reversed these findings and disagreed that Mr. Warhol’s use of the photograph constituted fair-use. The case subsequently went to the U.S. Supreme Court, which delivered its verdict on May 18, 2023.

The majority of judges concluded that if an original work and secondary work have more or less similar purposes and if the secondary use is of a commercial nature, the first factor may not favour a fair-use interpretation – unless there are other justifications for copying.

In this particular instance, according to the majority decision, both Ms. Goldsmith’s photos and Mr. Warhol’s adaptations had more or less the same purpose: to portray Prince. The majority said that while copying may have helped convey a new meaning or message, that in itself did not suffice under the first factor.

The dissenting opinion focused extensively on how art is produced, particularly the fact that no artists create anything out of a vacuum. Justice Elena Kagan, author of this opinion, wrote of the need for a broader reading of ‘transformative use’ for the progress of arts and science. The dissenters also opined that Mr. Warhol’s addition of important “new expression, meaning and message” tilted the first factor in favour of a finding of fair-use.

How does this affect generative AI?

A view of the ChatGPT website.

A view of the ChatGPT website.
| Photo Credit:
Rolf van Root/Unsplash

While this dispute arose in the context of use of a photograph as an artistic reference, the implications of the court’s finding are bound to ripple across the visual arts at large. The majority position could challenge the manner in which many generative artificial intelligence (AI) tools, such as ChatGPT4, MidJourney, and Stable Diffusion, have been conceived. These models’ makers ‘train’ them on text, photos, and videos strewn around the internet, copyrighted or not.

For example, if someone is using a generative AI tool to create pictures in the style of Mr. Warhol, and if the resulting images are similar to any of the work of Mr. Warhol, a court is likelier now to rule against this being described as fair use, taking the view that both the copyrighted work and the models’ output serve similar purposes.

The majority’s reliance on the commercial nature of the use may also result in substantial deviation from the established view: that the commercial nature of the use in itself cannot negate a finding of fair use. But the true extent of the implications of the verdict will be clear only when trial courts begin applying the ratio in this judgment to future cases.

What about Indian copyright law?

There may not be any direct implications for Indian copyright law, as the framework of exceptions here is different. India follows a hybrid model of exception in which fair dealing with copyrighted work is exempted for some specific purposes under Section 52(1)(a) of the Copyright Act 1957. India also has a long list of enumerated exceptions.

This said, the observations by the U.S. Supreme Court’s decision could have a persuasive effect, particularly when determining ‘fairness’ as part of a fair-dealing litigation. Then again, only time will tell which one will have a more persuasive effect – the majority or the minority.

Arul George Scaria is an associate professor at the National Law School of India University (NLSIU).

Source link

#Explained #photography #dispute #affect #ChatGPT #cousins

U.S. Supreme Court preserves access to abortion pill for now

The Supreme Court is seen on April 21, 2023, in Washington after the court decided to preserve women’s access to a drug used in the most common method of abortion, rejecting lower-court restrictions while a lawsuit continues. The justices on Friday granted emergency requests from the Biden administration and New York-based Danco Laboratories, maker of the drug mifepristone.
| Photo Credit: AP

The Supreme Court on Friday preserved women’s access to a drug used in the most common method of abortion, rejecting lower-court restrictions while a lawsuit continues.

The justices granted emergency requests from the Biden administration and New York-based Danco Laboratories, maker of the drug mifepristone. They are appealing a lower court ruling that would roll back Food and Drug Administration approval of mifepristone.

The drug has been approved for use in the U.S. since 2000 and more than 5 million people have used it. Mifepristone is used in combination with a second drug, misoprostol, in more than half of all abortions in the U.S.

The court’s action Friday almost certainly will leave access to mifepristone unchanged at least into next year, as appeals play out, including a potential appeal to the high court. The next stop for the case is at the New Orleans-based U.S. Court of Appeals for the 5th Circuit, which has set arguments in the case for May 17.

Two of the nine justices — Samuel Alito, the author of last year’s decision overturning Roe v. Wade, and Clarence Thomas — voted to allow restrictions to take effect, and Alito issued a four-page dissent. No other justices commented on the court’s one-paragraph order, and the court did not release a full vote breakdown.

President Joe Biden praised the high court for keeping mifepristone available while the court fight continues.

“The stakes could not be higher for women across America. I will continue to fight politically-driven attacks on women’s health. But let’s be clear — the American people must continue to use their vote as their voice, and elect a Congress who will pass a law restoring the protections of Roe v. Wade,” Mr. Biden said in a statement.

Alliance Defending Freedom, representing abortion opponents challenging the FDA’s approval of mifepristone, downplayed the court’s action.

“As is common practice, the Supreme Court has decided to maintain the status quo that existed prior to our lawsuit while our challenge to the FDA’s illegal approval of chemical abortion drugs and its removal of critical safeguards for those drugs moves forward,” ADF lawyer Erik Baptist said in a statement.

The justices weighed arguments that allowing restrictions contained in lower-court rulings to take effect would severely disrupt the availability of mifepristone.

The Supreme Court had initially said it would decide by Wednesday whether the restrictions could take effect while the case continues. A one-sentence order signed by Mr. Alito on Wednesday gave the justices two additional days, without explanation.

The challenge to mifepristone is the first abortion controversy to reach the nation’s highest court since its conservative majority overturned Roe v. Wade 10 months ago and allowed more than a dozen States to effectively ban abortion outright.

In his majority opinion last June, Mr, Alito said one reason for overturning Roe was to remove federal courts from the abortion fight. “It is time to heed the Constitution and return the issue of abortion to the people’s elected representatives,” he wrote.

But even with their court victory, abortion opponents returned to federal court with a new target: medication abortions, which make up more than half of all abortions in the United States.

Women seeking to end their pregnancies in the first 10 weeks without more invasive surgical abortion can take mifepristone, along with misoprostol. The FDA has eased the terms of mifepristone’s use over the years, including allowing it to be sent through the mail in states that allow access.

The abortion opponents filed suit in Texas in November, asserting that the FDA’s original approval of mifepristone 23 years ago and subsequent changes were flawed.

They won a ruling on April 7 by U.S. District Judge Matthew Kacsmaryk, an appointee of former President Donald Trump, revoking FDA approval of mifepristone. The judge gave the Biden administration and Danco Laboratories a week to appeal and seek to keep his ruling on hold.

Responding to a quick appeal, two more Trump appointees on the 5th U.S. Circuit Court of Appeals said the FDA’s original approval would stand for now. But Judges Andrew Oldham and Kurt Engelhardt said most of the rest of Kacsmaryk’s ruling could take effect while the case winds through federal courts.

Their ruling would have effectively nullified changes made by the FDA starting in 2016, including extending from seven to 10 weeks of pregnancy when mifepristone can be safely used. The court also would have halted sending the drug in the mail or dispensing it as a generic, and patients who seek it would have had to make three in-person visits with a doctor. Women also might have been required to take a higher dosage of the drug than the FDA says is necessary.

The administration and Danco have said that chaos would ensue if those restrictions were to take effect while the case proceeds. Potentially adding to the confusion, a federal judge in Washington has ordered the FDA to preserve access to mifepristone under the current rules in 17 Democratic-led states and the District of Columbia that filed a separate lawsuit.

The Biden administration has said the rulings conflict and create an untenable situation for the FDA.

Mr. Alito questioned the argument that chaos would result, saying the administration “has not dispelled doubts that it would even obey an unfavorable order in these cases.”

And a new legal wrinkle threatened even more complications. GenBioPro, which makes the generic version of mifepristone, filed a lawsuit Wednesday to preemptively block the FDA from removing its drug from the market, in the event that the Supreme Court doesn’t intervene.

The Supreme Court was only being asked to block the lower-court rulings through the end of the legal case.

The appeals court has sped up its review, but there is no timetable for a ruling.

Any appeal to the Supreme Court would follow within three months of a ruling, but with no deadline for the justices to decide whether to review the case.

Source link

#Supreme #Court #preserves #access #abortion #pill